Opioid use disorder

J Strang, ND Volkow, L Degenhardt… - Nature reviews Disease …, 2020 - nature.com
Opioid use disorder (OUD) is a chronic relapsing disorder that, whilst initially driven by
activation of brain reward neurocircuits, increasingly engages anti-reward neurocircuits that …

Management of opioid use disorder in the USA: present status and future directions

C Blanco, ND Volkow - The Lancet, 2019 - thelancet.com
Opioid use disorder is characterised by the persistent use of opioids despite the adverse
consequences of its use. The disorder is associated with a range of mental and general …

[HTML][HTML] CDC clinical practice guideline for prescribing opioids for pain—United States, 2022

D Dowell - MMWR. Recommendations and reports, 2022 - cdc.gov
This guideline provides recommendations for clinicians providing pain care, including those
prescribing opioids, for outpatients aged≥ 18 years. It updates the CDC Guideline for …

Comparative effectiveness of different treatment pathways for opioid use disorder

SE Wakeman, MR Larochelle, O Ameli… - JAMA network …, 2020 - jamanetwork.com
Importance Although clinical trials demonstrate the superior effectiveness of medication for
opioid use disorder (MOUD) compared with nonpharmacologic treatment, national data on …

CDC guideline for prescribing opioids for chronic pain—United States, 2016

D Dowell, TM Haegerich, R Chou - Jama, 2016 - jamanetwork.com
Importance Primary care clinicians find managing chronic pain challenging. Evidence of
long-term efficacy of opioids for chronic pain is limited. Opioid use is associated with serious …

Relationship between nonmedical prescription-opioid use and heroin use

WM Compton, CM Jones… - New England Journal of …, 2016 - Mass Medical Soc
Relationship between Nonmedical Prescription-Opioid Use and Heroin Use | New England
Journal of Medicine Skip to main content Access provided byTE WHATU ORA HEALTH NEW …

Management of opioid use disorders: a national clinical practice guideline

J Bruneau, K Ahamad, MÈ Goyer, G Poulin, P Selby… - Cmaj, 2018 - Can Med Assoc
Methods The Canadian Research Initiative in Substance Misuse (CRISM), a Canadian
Institutes of Health Research (CIHR)–funded research network composed of four regional …

Medication-assisted treatment of opioid use disorder: review of the evidence and future directions

HS Connery - Harvard review of psychiatry, 2015 - journals.lww.com
Learning Objective: After participating in this activity, learners should be better able to:
Evaluate the rationale for and current evidence supporting medication-assisted treatment of …

Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X: BOT): a multicentre, open-label …

JD Lee, EV Nunes, P Novo, K Bachrach, GL Bailey… - The Lancet, 2018 - thelancet.com
Background Extended-release naltrexone (XR-NTX), an opioid antagonist, and sublingual
buprenorphine-naloxone (BUP-NX), a partial opioid agonist, are pharmacologically and …

[HTML][HTML] A systematic review on the use of psychosocial interventions in conjunction with medications for the treatment of opioid addiction

K Dugosh, A Abraham, B Seymour… - Journal of addiction …, 2016 - journals.lww.com
Opioid use and overdose rates have risen to epidemic levels in the United States during the
past decade. Fortunately, there are effective medications (ie, methadone, buprenorphine …